{"id":809,"date":"2021-04-18T07:30:00","date_gmt":"2021-04-18T06:30:00","guid":{"rendered":"http:\/\/molecularhealth.com\/eu\/70-jaehrige-mit-rezidiviertem-ovarialkarzinom\/"},"modified":"2023-05-08T14:59:03","modified_gmt":"2023-05-08T13:59:03","slug":"70-jaehrige-mit-rezidiviertem-ovarialkarzinom","status":"publish","type":"post","link":"https:\/\/molecularhealth.com\/eu\/de\/70-jaehrige-mit-rezidiviertem-ovarialkarzinom\/","title":{"rendered":"70-J\u00e4hrige mit rezidiviertem Ovarialkarzinom"},"content":{"rendered":"\n<p>Nach mehreren Therapien und Rezidiven kam es bei einer 70-j\u00e4hrigen Patientin mit fortgeschrittenem Ovarialkarzinom zum erneuten Progress. Der Einsatz von Molecular Health Guide (MH Guide) lieferte dem molekularen Tumorboard umfassende Erkenntnisse und individuelle Therapieempfehlungen. <\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:25%\"><div class=\"lazyblock-mh-buttons-bar-Z24jqzT wp-block-lazyblock-mh-buttons-bar\">  <section class=\"mh-buttons-bar\">\r\n          <a class=\"mh-buttons-item\" href=\"https:\/\/molecularhealth.com\/wp-content\/uploads\/sites\/2\/Beitrag_9-Patientenfall_70-J\u201ehrige-mit-rezidiviertem-Ovarialkarzinom.pdf\" target=\"_self\"><i data-feather=\"arrow-right\"><\/i> <span>Zum Whitepaper<\/span><\/a>      <\/section>\r\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:25%\"><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Nach mehreren Therapien und Rezidiven kam es bei einer 70-j\u00e4hrigen Patientin mit fortgeschrittenem Ovarialkarzinom zum erneuten Progress. Der Einsatz von Molecular Health Guide (MH Guide) lieferte dem molekularen Tumorboard umfassende Erkenntnisse und individuelle Therapieempfehlungen.<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","inline_featured_image":false,"footnotes":""},"categories":[35,47,46],"tags":[],"class_list":["post-809","post","type-post","status-publish","format-standard","hentry","category-molecular-analysis-solutions-de","category-whitepaper","category-2021-de"],"acf":[],"_links":{"self":[{"href":"https:\/\/molecularhealth.com\/eu\/de\/wp-json\/wp\/v2\/posts\/809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/molecularhealth.com\/eu\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/molecularhealth.com\/eu\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/molecularhealth.com\/eu\/de\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/molecularhealth.com\/eu\/de\/wp-json\/wp\/v2\/comments?post=809"}],"version-history":[{"count":6,"href":"https:\/\/molecularhealth.com\/eu\/de\/wp-json\/wp\/v2\/posts\/809\/revisions"}],"predecessor-version":[{"id":1208,"href":"https:\/\/molecularhealth.com\/eu\/de\/wp-json\/wp\/v2\/posts\/809\/revisions\/1208"}],"wp:attachment":[{"href":"https:\/\/molecularhealth.com\/eu\/de\/wp-json\/wp\/v2\/media?parent=809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/molecularhealth.com\/eu\/de\/wp-json\/wp\/v2\/categories?post=809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/molecularhealth.com\/eu\/de\/wp-json\/wp\/v2\/tags?post=809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}